New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 13, 2014
11:41 EDTOREX, IDIX, BDSI, NSR, MONT, ULTA, LULU, OPEN, RHOptions with decreasing implied volatility
Options with decreasing implied volatility: OREX IDIX BDSI NSR MONT ULTA LULU OPEN RH HSH
News For OREX;IDIX;BDSI;NSR;MONT;ULTA;LULU;OPEN;RH From The Last 14 Days
Check below for free stories on OREX;IDIX;BDSI;NSR;MONT;ULTA;LULU;OPEN;RH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 8, 2014
10:36 EDTOREX, ULTAOptions with increasing implied volatility
Subscribe for More Information
10:32 EDTLULUlululemon advances after founder sells shares to PE investor
Subscribe for More Information
09:15 EDTLULUOn The Fly: Pre-market Movers
HIGHER: NVIDIA (NVDA), up 4.2%, upgraded at Needham following its better than expected Q2 results... Arista Networks (ANET), up 8%, upgraded at Citigroup following better than expected Q2 results, announcing an expanded strategic relationship with VMware (VMW)... Tekmira Pharmaceuticals (TKMR), up 17.5% after announcing that the FDA verbally confirmed they have modified the full clinical hold placed on its TKM-Ebola treatment to a partial clinical hold... Gap (GPS), up 4.7% after July same-store sales rose 2%, company issues Q2 EPS outlook above the consensus estimate... lululemon (LULU), up 2.4% after founder agrees to sell half his stake to Advent for $845M. UP AFTER EARNINGS: SolarCity (SCTY), up 1%... Assured Guaranty (AGO), up 9%... MercadoLibre (MELI), up 13.6%. LOWER: Zynga (ZNGA), down 6% after lowering fiscal 2014 guidance... McDonald's (MCD), down 0.4% after Chinese supplier issue contributes to July comparable sales drop of 2.5%.
09:00 EDTBDSIBioDelivery Sciences still a takeover target, says Janney Capital
Janney Capital continues to believe that BioDelivery Sciences (BDSI) could be a takeover target, noting that it thinks partner Endo International (ENDP) could be a potential buyer if BioDelivery has more positive top-line results and if the market weakens. The firm, which added that it likes BioDelivery Sciences as a stand-alone company as well, maintains its Buy rating and $15 fair value estimate on the stock.
08:21 EDTLULUOptions expected to be active
Subscribe for More Information
07:40 EDTLULUlululemon fundamental risk remains after founder sale, says Jefferies
Subscribe for More Information
06:53 EDTLULULululemon volatility expected to move, founder will sell half his stake
Subscribe for More Information
05:59 EDTLULUStocks with implied volatility movement; MNKD LULU
Stocks with implied volatility movement; MannKind (MNKD) 116, lululemon (LULU) 39 according to iVolatility.
August 7, 2014
18:41 EDTLULUOn The Fly: After Hours Movers
Subscribe for More Information
17:29 EDTBDSIBioDelivery Sciences sees U.S. launch of Bunavail in late Q3
Subscribe for More Information
17:27 EDTBDSIBioDelivery Sciences reports Q2 EPS (14c), consensus (13c)
Subscribe for More Information
16:56 EDTLULUlululemon founder to sell half his stake to Advent for $845M
Subscribe for More Information
16:25 EDTLULUlululemon jumps 9% after Dow says founder to sell half his stake
16:25 EDTLULUlululemon founder to sell half his stake to Advent, Dow reports
lululemon founder Chip Wilson will sell half his stake to private equity firm Advent for $845M and Advent will receive two board seats and review the company's governance, Dow Jones reports, citing sources. The deal takes a proxy fight and potential hostile buyout off the table for now, Dow adds.
13:22 EDTMONTMontage Technology downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Montage Technology to Hold following the company's Q2 results on expectations its takeover by PDSTI will be completed.
10:51 EDTOREXOptions with increasing implied volatility
Subscribe for More Information
07:55 EDTOREXOrexigen to host conference call
Conference Call to discuss 2Q14 earnings, as well as provide an update on the NB32 review will be held on August 7 at 8 am. Webcast Link
07:12 EDTOREXOrexigen reports Q2 EPS (21c), consensus (21c)
Subscribe for More Information
06:40 EDTMONTMontage Technology sees Q3 revenue $41M-$45M, consensus $41.64M
Sees Q3 gross margin 56%-59%.
06:39 EDTMONTMontage Technology reports Q2 adjusted EPS 30c, consensus 37c
Reports Q2 revenue $40.4M, consensus $38.02M.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use